Korea Health Ministry Committee Approves New Price-Volume Formula For Drugs Over Industry Opposition
This article was originally published in PharmAsia News
Executive Summary
A new price-volume formula in Korea could lead to additional price cuts on blockbuster medications and lead to some compounds not being listed for government reimbursement after implementation next year.